Trends in the pharmacological management of atrial fibrillation in UK general practice 2008-2018.
Katherine PhillipsAnuradhaa SubramanianGraham Neil ThomasNazish KhanJoht Singh ChandanPaul BradyTom MarshallKrishnarajah NirantharakumarLarissa FabritzNicola Jaime AdderleyPublished in: Heart (British Cardiac Society) (2021)
There has been an increase in the proportion of patients with AF appropriately prescribed anticoagulants following National Institute for Health and Care Excellence and European Society of Cardiology guidelines, which correlates with improvements in mortality and stroke outcomes. Beta-blockers appear increasingly favoured over digoxin for rate control. There has been a steady decline in GP prescribing rates for rhythm control drugs, possibly related to concerns over efficacy and safety and increased availability of AF ablation.
Keyphrases
- atrial fibrillation
- general practice
- catheter ablation
- primary care
- healthcare
- left atrial
- oral anticoagulants
- left atrial appendage
- direct oral anticoagulants
- quality improvement
- heart failure
- public health
- cardiovascular events
- mental health
- palliative care
- percutaneous coronary intervention
- clinical practice
- cardiac surgery
- cross sectional
- health information
- cardiovascular disease
- angiotensin converting enzyme
- pain management
- radiofrequency ablation
- adverse drug
- emergency department
- skeletal muscle
- human health
- coronary artery disease
- adipose tissue
- acute coronary syndrome
- metabolic syndrome
- subarachnoid hemorrhage
- brain injury
- venous thromboembolism
- angiotensin ii
- social media
- cerebral ischemia